Similar Efficacy of Ciclesonide Once Daily Versus Fluticasone Propionate Twice Daily in Patients with Persistent Asthma

References

• Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000; 343: 332–336
   PubMed Web of Science ®Google Scholar
• Hanania N A, Chapman K R, Kesten S. Adverse effects of inhaled corticosteroids. Am J Med 1995; 98: 196–208
   PubMed Web of Science ®Google Scholar
• Georgitis J W. The 1997 Asthma Management Guidelines and therapeutic issues relating to the treatment of asthma. National Heart, Lung, and Blood Institute. Chest 1999; 115: 210–217
   Google Scholar
• Barnes P J. Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma. J Allergy Clin Immunol 1998; 101: S427–433
   PubMed Web of Science ®Google Scholar
• Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001; 107: 937–944
   PubMed Web of Science ®Google Scholar
• Toogood J H. Side effects of inhaled corticosteroids. J Allergy Clin Immunol 1998; 102: 705–713
   PubMed Web of Science ®Google Scholar
• Global asthma physician and patient (GAPP) survey. 2006, www.gappsurvey.org Last accessed 2006
   Google Scholar
• Barnes P J. The role of inflammation and anti-inflammatory medication in asthma. Respir Med 2002; 96: S9–15, Suppl A
   PubMed Web of Science ®Google Scholar
• Busse W W, Rosenwasser L J. Mechanisms of asthma. J Allergy Clin Immunol 2003; 111: S799–804
   PubMed Web of Science ®Google Scholar
• Hansel T T, Barnes P J. Novel drugs for treating asthma. Curr Allergy Asthma Rep 2001; 1: 164–173
   PubMedGoogle Scholar
• Mann M, Eliasson O, Patel K, Zu Wallack R L. A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest 1992; 101: 496–499
   PubMed Web of Science ®Google Scholar
• Belvisi M G, Hele D J. Soft steroids: a new approach to the treatment of inflammatory airways diseases. Pulm Pharmacol Ther 2003; 16: 321–325
   PubMed Web of Science ®Google Scholar
• Stoeck M, Riedel R, Hochhaus G, Hafner D, Masso J M, Schmidt B, et al. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide. J Pharmacol Exp Ther 2004; 309: 249–258
   PubMed Web of Science ®Google Scholar
• Rohatagi S, Arya V, Zech K, Nave R, Hochhaus G, Jensen B K, et al. Population pharmacokinetics and pharmacodynamics of ciclesonide. J Clin Pharmacol 2003; 43: 365–378
   PubMed Web of Science ®Google Scholar
• Lee D K, Fardon T C, Bates C E, Haggart K, McFarlane L C, Lipworth B J. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma. Chest 2005; 127: 851–860
   PubMed Web of Science ®Google Scholar
• Rohatagi S, Appajosyula S, Derendorf H, Szefler S, Nave R, Zech K, et al. Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective. J Clin Pharmacol 2004; 44: 37–47
   PubMed Web of Science ®Google Scholar
• Postma D S, Sevette C, Martinat Y, Schlosser N, Aumann J, Kafe H. Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening. Eur Respir J 2001; 17: 1083–1088
   PubMed Web of Science ®Google Scholar
• Chapman K R, Patel P, D'Urzo A D, Alexander M, Mehra S, Oedekoven C, et al. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma. Allergy 2005; 60: 330–337
   PubMed Web of Science ®Google Scholar
• Derom E, Van De Velde V, Marissens S, Engelstatter R, Vincken W, Pauwels R. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5′monophosphate in asthmatic patients. Pulm Pharmacol Ther 2005; 18: 328–336
   PubMed Web of Science ®Google Scholar
• Chapman K R, Patel P, Boulet L P, D'Urzo A D, Alexander M, Mehra S, et al. Efficacy and long-term safety of ciclesonide in asthmatic patients as demonstrated in a 52 week long study. Eur Respir J 2002; 20: 373s, (Suppl. 38)
   Google Scholar
• Pearlman D S, Berger W E, Kerwin E, Laforce C, Kundu S, Banerji D. Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma. J Allergy Clin Immunol 2005; 116: 1206–1212
   PubMed Web of Science ®Google Scholar
• Buhl R, Vinkler I, Magyar P, Gyori Z, Rybacki C, Middle M V, et al. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma. Pulm Pharmacol Ther 2006; 19: 404–412
   PubMed Web of Science ®Google Scholar
• Guidelines for the evaluation of impairment/disability in patients with asthma. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis 1993; 147: 1056–1061
   PubMed Web of Science ®Google Scholar
• Chervinsky P, van As A, Bronsky E A, Dockhorn R, Noonan M, La Force C, et al. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group. J Allergy Clin Immunol 1994; 94: 676–683
   PubMed Web of Science ®Google Scholar
• Sheffer A L, La Force C, Chervinsky P, Pearlman D, Schaberg A. Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group. J Fam Pract 1996; 42: 369–375
   Google Scholar
• Wolfe J D, Selner J C, Mendelson L M, Hampel F, Jr., Schaberg A. Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study. Clin Ther 1996; 18: 635–646
   PubMed Web of Science ®Google Scholar
• Purucker M E, Rosebraugh C J, Zhou F, Meyer R J. Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a day. Chest 2003; 124: 1584–1593
   PubMed Web of Science ®Google Scholar
• Nave R, Fisher R, Zech K. In Vitro metabolism of ciclesonide in human lung and liver precision-cut tissue slices. Biopharm Drug Dispos 2006; 27: 197–207
   PubMed Web of Science ®Google Scholar
• Issar M, Sahasranaman S, Buchwald P, Hochhaus G. Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids. Eur Respir J 2006; 27: 511–516
   PubMed Web of Science ®Google Scholar
• Miller-Larsson A, Mattsson H, Hjertberg E, Dahlback M, Tunek A, Brattsand R. Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue. Drug Metab Dispos 1998; 26: 623–630
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Allen D, Milanowski J, Kalev I, Willits L, Davies P. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics 2004; 113: e87–e94
   PubMed Web of Science ®Google Scholar
• Derendorf H, Hochhaus G, Meibohm B, Mollmann H, Barth J. Pharmacokinetics and pharmacodynamics of inhaled corticosteroids. J Allergy Clin Immunol 1998; 101: S440–S446
   PubMed Web of Science ®Google Scholar
• Mollmann H, Wagner M, Meibohm B, Hochhaus G, Barth J, Stockmann R, et al. Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration. Eur J Clin Pharmacol 1998; 53: 459–467
   PubMed Web of Science ®Google Scholar
• LaForce C F, Pearlman D S, Ruff M E, Silvers W S, Weinstein S W, Clements D S, et al. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma. Ann Allergy Asthma Immunol 2000; 85: 407–415
   PubMed Web of Science ®Google Scholar
• Santanello N C, Zhang J, Seidenberg B, Reiss T F, Barber B L. What are minimal important changes for asthma measures in a clinical trial?. Eur Respir J 1999; 14: 23–27
   PubMed Web of Science ®Google Scholar
• Boulet L P, Cowie R L, Negro R D, Brett W, Gold M, Marques A, et al. Comparison of once- with twice-daily dosing of fluticasone propionate in mild and moderate asthma. Can Respir J 2000; 7: 239–247
   PubMedGoogle Scholar
• Reynolds N A, Scott L J. Ciclesonide. Drugs 2004; 64: 511–9, discussion 20–21
   PubMed Web of Science ®Google Scholar
• Lipworth B J, Kaliner M A, La Force C F, Baker J W, Kaiser H B, Amin D, et al. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma. Ann Allergy Asthma Immunol 2005; 94: 465–472
   PubMed Web of Science ®Google Scholar
• Richter K, Kanniess F, Biberger C, Nave R, Magnussen H. Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma. J Clin Pharmacol 2005; 45: 146–152
   PubMed Web of Science ®Google Scholar